3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
9
Glioma
9
Osteosarcoma
8
Neuroblastoma
8
Multiple Myeloma
8
Leukemia, Myeloid, Acute
8
Sarcoma
7
Rhabdoid Tumor
7
Prostatic Neoplasms
7
Neoplasm Metastasis
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Rhabdomyosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Lymphoma
6
Lung Neoplasms
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myelodysplastic Syndromes
5
Central Nervous System Neoplasms
5
Carcinoma, Hepatocellular
5
Sarcoma, Ewing
4
Ovarian Neoplasms
4
Melanoma
4
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
3
Interventions
pembrolizumab
6
avelumab
6
Nivolumab
5
Specimen Handling
4
Magnetic Resonance Spectroscopy
3
Biopsy
3
prednylidene
2
lutetium Lu 177 dotatate
2
deltacortene
2
Prednisone
2
Ipilimumab
2
CTLA-4 Antigen
2
talimogene laherparepvec
1
lenvatinib
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
aldesleukin
1
Tacrolimus
1
Sirolimus
1
Saline Solution
1
Radiotherapy
1
Radiosurgery
1
MAPRE1 protein, human
1
Lutetium-177
1
Laparoscopy
1
Exercise Test
1
Cyclophosphamide
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Merkel Cell
×
X-Rays
×
90 days
×
Clear all
No trials found.